3
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22405 | Pravastatin | Others | Others |
Pravastatin is a lipoprotein-lowering drug via reversibly inhibiting hydroxymethylglutaryl-CoA (HMG-CoA) reductase and the synthesis of very-low-density lipoproteins. | |||
T37642 |
Pravastatin lactone
|
||
Pravastatin lactone is a metabolite of pravastatin , a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor that is a ring-hydroxylated metabolite of mevastatin . Pravastatin lactone is formed when pravastatin undergoes acid-catalyzed non-enzymatic lactonization in the stomach following oral administration. | |||
T40913 |
3α-Hydroxy pravastatin sodium
|
||
3α-Hydroxy pravastatin sodium, the primary metabolite of Pravastatin, is a potent competitive inhibitor of HMG-CoA reductase. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0672 |
Pravastatin sodium
CS-514 Sodium,普伐他汀钠,CS-514 (sodium) |
Ferroptosis; HMG-CoA Reductase; Autophagy | Apoptosis; Autophagy; Metabolism |
Pravastatin sodium (CS-514 (sodium)) 是一种 HMG-CoA 还原酶抑制剂,抑制甾醇合成,IC50 为 5.6 μM。 |